Denali Therapeutics - 48 Year Dividend History | DNLI

Historical dividend payout and yield for Denali Therapeutics (DNLI) since 1971. The current TTM dividend payout for Denali Therapeutics (DNLI) as of April 18, 2019 is $0.00. The current dividend yield for Denali Therapeutics as of April 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.398B $0.129B
Denali Therapeutics Inc. is a biotechnology company. It focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and others. Denali Therapeutics Inc. is based in SOUTH SAN FRANCISCO, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.312B 12.32
Gilead Sciences (GILD) United States $80.293B 10.22
Bio-Techne Corp (TECH) United States $7.144B 48.13